Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |